The University of Manchester is a part of the International Alliance for Cancer Early Detection (ACED). Launched in 2019, ACED is a £55 million partnership between Cancer Research UK, the Canary Center at Stanford University, the University of Cambridge, the Knight Cancer Institute at OHSU, University College London (UCL), and the University of Manchester.
About ACED Manchester
ACED is a £55 million partnership between world-leading early detection institutes and organisations dedicated to improving the early detection of cancer.
ACED Manchester's research is prioritised across three key research themes and several disease sites.
Training and Development
A core goal at ACED Manchester is to enable the next-generation of early detection research scientists to become future leaders.
Discover the opportunities for ACED Member organisations to lever additional ACED funding in strategic areas.